Response to in vitro and physiologically‐based pharmacokinetic assessment of the drug–drug interaction potential of canagliflozin

Por Miners, John O., Pattanawongsa, Attarat, Rowland, Andrew
Publicado no Br J Clin Pharmacol (2017)

Renal drug metabolism in humans: the potential for drug–endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT)

Por Knights, Kathleen M, Rowland, Andrew, Miners, John O
Publicado em 2013

Pharmacogenomic substudies of randomized controlled trials: consideration of safety outcomes

Por Sorich, Michael J., Rowland, Andrew, Wiese, Michael D.
Publicado em 2014

Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availability

Por Hopkins, Ashley M., Rowland, Andrew, Sorich, Michael J.
Publicado no BMC Med (2018)

Predictors of anti-VEGF drug-induced hypertension using different hypertension criteria: a secondary analysis of the COMPARZ study

Por Mangoni, Arduino A., Kichenadasse, Ganessan, Rowland, Andrew, Sorich, Michael J.
Publicado no Ther Adv Med Oncol (2018)

Pharmacists in Australian general practice: an opportunity for expertise in precision medicine

Por Polasek, Thomas M., Rowland, Andrew, Wiese, Michael D., Sorich, Michael J.
Publicado no Ther Adv Drug Saf (2015)

Diagnostic accuracy of PAT-POPS and ManChEWS for admissions of children from the emergency department

Por Cotterill, Sarah, Rowland, Andrew G, Kelly, Jacqueline, Lees, Helen, Kamara, Mohammed
Publicado no Emerg Med J (2016)

Optimized Cocktail Phenotyping Study Protocol Using Physiological Based Pharmacokinetic Modeling and In silico Assessment of Metabolic Drug–Drug Interactions Involving Modafinil

Por Rowland, Angela, Mangoni, Arduino A., Hopkins, Ashley, Sorich, Michael J., Rowland, Andrew
Publicado no Front Pharmacol (2016)

Risk factors of proteinuria in renal cell carcinoma patients treated with VEGF inhibitors: a secondary analysis of pooled clinical trial data

Por Sorich, Michael J, Rowland, Andrew, Kichenadasse, Ganessan, Woodman, Richard J, Mangoni, Arduino A
Publicado no Br J Cancer (2016)

Risk Factors for Severe Diarrhea with an Afatinib Treatment of Non-Small Cell Lung Cancer: A Pooled Analysis of Clinical Trials

Por Hopkins, Ashley M., Nguyen, Anh-Minh, Karapetis, Christos S., Rowland, Andrew, Sorich, Michael J.
Publicado no Cancers (Basel) (2018)

Huntington disease among the Navajo: A population-based study in the Navajo Nation

Por Gordon, Paul H., Mehal, Jason M., Rowland, Andrew S., Cheek, James E., Bartholomew, Michael L.
Publicado no Neurology (2016)

Evaluation of modafinil as a perpetrator of metabolic drug–drug interactions using a model informed cocktail reaction phenotyping trial protocol

Por Rowland, Angela, van Dyk, Madelé, Warncken, David, Mangoni, Arduino A., Sorich, Michael J., Rowland, Andrew
Publicado no Br J Clin Pharmacol (2018)

Prevalence of Medication Treatment for Attention Deficit–Hyperactivity Disorder Among Elementary School Children in Johnston County, North Carolina

Por Rowland, Andrew S., Umbach, David M., Stallone, Lil, Naftel, A. Jack, Bohlig, E. Michael, Sandler, Dale P.
Publicado em 2002

Refining and testing the diagnostic accuracy of an assessment tool (PAT-POPS) to predict admission and discharge of children and young people who attend an emergency department: pr...

Por Riaz, Samah, Rowland, Andrew, Woby, Steve, Long, Tony, Livesley, Joan, Cotterill, Sarah, Heal, Calvin, Roland, Damian
Publicado no BMC Pediatr (2018)

Sources of Potential Lead Exposure Among Pregnant Women in New Mexico

Por Bakhireva, Ludmila N., Rowland, Andrew S., Young, Bonnie N., Cano, Sandra, Phelan, Sharon T., Artyushkova, Kateryna, Rayburn, William F., Lewis, Johnnye
Publicado em 2013

A pilot study comparing observational and questionnaire measures as surrogates of residential pesticide exposures among residents impacted by the Ecuadorian Cut-Flower Farming indu...

Por Handal, Alexis J., McGough-Maduena, Alison, Páez, Maritza, Skipper, Betty, Rowland, Andrew S., Fenske, Richard A., Harlow, Siobán D.
Publicado no Arch Environ Occup Health (2015)

Reply: Comment on ‘Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal-antibody therapy for RAS wild-type metastatic colorectal cancer'

Por Rowland, Andrew, Dias, Mafalda M, Wiese, Michael D, Kichenadasse, Ganessan, McKinnon, Ross A, Karapetis, Christos S, Sorich, Michael J
Publicado no Br J Cancer (2015)

Attention-Deficit/Hyperactivity Disorder (ADHD): Interaction between socioeconomic status and parental history of ADHD determines prevalence

Por Rowland, Andrew S., Skipper, Betty J., Rabiner, David L., Qeadan, Fares, Campbell, Richard A., Naftel, A. Jack, Umbach, David M.
Publicado no J Child Psychol Psychiatry (2017)

The prevalence of ADHD in a population-based sample

Por Rowland, Andrew S., Skipper, Betty J., Umbach, David M., Rabiner, David L., Campbell, Richard A., Naftel, A. Jack, Sandler, Dale P.
Publicado em 2013

Targeted pharmacotherapy after somatic cancer mutation screening

Por Polasek, Thomas M., Ambler, Karen, Scott, Hamish S., Sorich, Michael J., Kaub, Peter A., Rowland, Andrew, Wiese, Michael D., Kichenadasse, Ganessan
Publicado no F1000Res (2016)